Cargando…

Detection of HIV-1 Neutralizing Antibodies in a Human CD4(+)/CXCR4(+)/CCR5(+) T-Lymphoblastoid Cell Assay System

Sensitive assays are needed to meaningfully assess low levels of neutralizing antibodies (NAbs) that may be important for protection against the acquisition of HIV-1 infection in vaccine recipients. The current assay of choice uses a non-lymphoid cell line (TZM-bl) that may lack sensitivity owing to...

Descripción completa

Detalles Bibliográficos
Autores principales:	McLinden, Robert J., LaBranche, Celia C., Chenine, Agnès-Laurence, Polonis, Victoria R., Eller, Michael A., Wieczorek, Lindsay, Ochsenbauer, Christina, Kappes, John C., Perfetto, Stephen, Montefiori, David C., Michael, Nelson L., Kim, Jerome H.
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Public Library of Science 2013
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3842913/ https://www.ncbi.nlm.nih.gov/pubmed/24312168 http://dx.doi.org/10.1371/journal.pone.0077756

Ejemplares similares

Optimization and validation of the HIV-1 neutralizing antibody assay in A3R5 cells
por: Sarzotti-Kelsoe, M, et al.
Publicado: (2012)

Impact of HIV-1 Backbone on Neutralization Sensitivity: Neutralization Profiles of Heterologous Envelope Glycoproteins Expressed in Native Subtype C and CRF01_AE Backbone
por: Chenine, Agnès-Laurence, et al.
Publicado: (2013)

P05-04. Neutralizing antibodies induced by immunization with liposomal gp41 peptide simultaneously bind to both the 2F5 or 4E10 epitope and lipid epitopes
por: Matyas, GR, et al.
Publicado: (2009)

Transmission of highly virulent CXCR4 tropic HIV-1 through the mucosal route in an individual with a wild-type CCR5 genotype
por: Song, Hongshuo, et al.
Publicado: (2023)

P04-23. HIV-1 neutralization is impacted by the PBMC donor used for both virus growth and target cells, and the effects are neutralization reagent-specific
por: Wieczorek, L, et al.
Publicado: (2009)

P04-12. Characterization of leukopak PBMC phenotypes and biotypes for optimal performance in HIV-1 neutralization assays
por: Brown, BK, et al.
Publicado: (2009)

The Role of Natural Killer (NK) Cells and NK Cell Receptor Polymorphisms in the Assessment of HIV-1 Neutralization
por: Brown, Bruce K., et al.
Publicado: (2012)

Magnitude and Breadth of the Neutralizing Antibody Response in the RV144 and Vax003 HIV-1 Vaccine Efficacy Trials
por: Montefiori, David C., et al.
Publicado: (2012)

CCR3, CCR4, CCR5, and CXCR3 expression in peripheral blood CD4+ lymphocytes in gastric cancer patients
por: Andalib, Alireza, et al.
Publicado: (2013)

Prognostic value of immunoexpression of CCR4, CCR5, CCR7 and CXCR4 in squamous cell carcinoma of tongue and floor of the mouth
por: Domingueti, Catherine-Bueno, et al.
Publicado: (2019)

CCR5 and CXCR4 antagonist and agonist binding sites
por: Teintze, Martin, et al.
Publicado: (2006)

Spermine and spermidine bind CXCR4 and inhibit CXCR4- but not CCR5-tropic HIV-1 infection
por: Harms, Mirja, et al.
Publicado: (2023)

Mice Transgenic for CD4-Specific Human CD4, CCR5 and Cyclin T1 Expression: A New Model for Investigating HIV-1 Transmission and Treatment Efficacy
por: Seay, Kieran, et al.
Publicado: (2013)

Structural basis of dimerization of chemokine receptors CCR5 and CXCR4
por: Di Marino, Daniele, et al.
Publicado: (2023)

HIV transmitted/founder vaccines elicit autologous tier 2 neutralizing antibodies for the CD4 binding site
por: McCurley, Nathanael P., et al.
Publicado: (2017)

CTLA-4 Blockade, during HIV Virus-Like Particles Immunization, Alters HIV-Specific B-Cell Responses
por: Lewis, Phoebe E., et al.
Publicado: (2020)

Stromal Down-Regulation of Macrophage CD4/CCR5 Expression and NF-κB Activation Mediates HIV-1 Non-Permissiveness in Intestinal Macrophages
por: Shen, Ruizhong, et al.
Publicado: (2011)

The HIV-1 Gp120/CXCR4 Axis Promotes CCR7 Ligand-Dependent CD4 T Cell Migration: CCR7 Homo- and CCR7/CXCR4 Hetero-Oligomer Formation as a Possible Mechanism for Up-Regulation of Functional CCR7
por: Hayasaka, Haruko, et al.
Publicado: (2015)

Coexpression of CCR7 and CXCR4 During B Cell Development Controls CXCR4 Responsiveness and Bone Marrow Homing
por: Mcheik, Saria, et al.
Publicado: (2019)

Establishment of a novel CCR5 and CXCR4 expressing CD4(+ )cell line which is highly sensitive to HIV and suitable for high-throughput evaluation of CCR5 and CXCR4 antagonists
por: Princen, Katrien, et al.
Publicado: (2004)

Signal Transduction Due to HIV-1 Envelope Interactions with Chemokine Receptors CXCR4 or CCR5
por: Davis, Craig B., et al.
Publicado: (1997)

Modified Newcastle Disease virus as an improved vaccine vector against Simian Immunodeficiency virus
por: Manoharan, Vinoth K., et al.
Publicado: (2018)

CCR5/CXCR4 Dual Antagonism for the Improvement of HIV Infection Therapy
por: Grande, Fedora, et al.
Publicado: (2019)

CXCR4-CCR7 Heterodimerization Is a Driver of Breast Cancer Progression
por: Poltavets, Valentina, et al.
Publicado: (2021)

Mucosal Immunization with Newcastle Disease Virus Vector Coexpressing HIV-1 Env and Gag Proteins Elicits Potent Serum, Mucosal, and Cellular Immune Responses That Protect against Vaccinia Virus Env and Gag Challenges
por: Khattar, Sunil K., et al.
Publicado: (2015)

P19-41. Full-length IMC expressing Renilla luciferase for neutralization assay using PBMC
por: Chenine, A, et al.
Publicado: (2009)

Comparative Immunogenicity of HIV-1 gp160, gp140 and gp120 Expressed by Live Attenuated Newcastle Disease Virus Vector
por: Khattar, Sunil K., et al.
Publicado: (2013)

Correction: Comparative Immunogenicity of HIV-1 gp160, gp140 and gp120 Expressed by Live Attenuated Newcastle Disease Virus Vector
por: Khattar, Sunil K., et al.
Publicado: (2014)

Consequences of ChemR23 Heteromerization with the Chemokine Receptors CXCR4 and CCR7
por: de Poorter, Cédric, et al.
Publicado: (2013)

In vivo effect of statins on the expression of the HIV co-receptors CCR5 and CXCR4
por: Higuita, Edwin A, et al.
Publicado: (2013)

Resistance to the CCR5 Inhibitor 5P12-RANTES Requires a Difficult Evolution from CCR5 to CXCR4 Coreceptor Use
por: Nedellec, Rebecca, et al.
Publicado: (2011)

E4orf1 Suppresses E1B-Deleted Adenovirus Vaccine-Induced Immune Responses
por: Sangare, Kotou, et al.
Publicado: (2022)

Inhibition of HIV-1 infection of peripheral blood mononuclear cells by a monoclonal antibody that binds to phosphoinositides and induces secretion of β-chemokines
por: Matyas, Gary R., et al.
Publicado: (2010)

Antigenicity and immunogenicity of a novel, acute HIV-1 Tanzanian subtype C gp145 envelope protein for clinical development
por: Polonis, V, et al.
Publicado: (2012)

Breadth and magnitude of antigen-specific antibody responses in the control of plasma viremia in simian immunodeficiency virus infected macaques
por: Pahar, Bapi, et al.
Publicado: (2016)

Identification of an unique CXCR4 epitope whose ligation inhibits infection by both CXCR4 and CCR5 tropic human immunodeficiency type-I viruses
por: Adachi, Tetsuya, et al.
Publicado: (2011)

Transmitted/Founder and Chronic Subtype C HIV-1 Use CD4 and CCR5 Receptors with Equal Efficiency and Are Not Inhibited by Blocking the Integrin α4β7
por: Parrish, Nicholas F., et al.
Publicado: (2012)

131 Expression of Chemokine Receptors CCR1, CCR3, CCR4, CCR5, CCR8 and CXCR3 in Human Nasal Polyps (NP); Comparison With NP From Allergic Patients With Aspirin Intolerance
por: Fundova, Petra, et al.
Publicado: (2012)

Recombinant soluble CCR5 AND CXCR4 chemokine receptors as anti-HIV drug targets
por: Kurbatska, Victoria, et al.
Publicado: (2010)

Localized CCR2 Activation in the Bone Marrow Niche Mobilizes Monocytes by Desensitizing CXCR4
por: Jung, Hosung, et al.
Publicado: (2015)

Cannot write session to /tmp/vufind_sessions/sess_0o8haut9h2gj69lp78emh0160v